Human insulin via MMP® for treating atrophic acne scars: a pilot study Insulina humana via MMP® para cicatrizes atróficas de acne: estudo piloto.
Human insulin via MMP® for treating atrophic acne scars: a pilot study Insulina humana via MMP® para cicatrizes atróficas de acne: estudo piloto.
-
DOI: https://doi.org/10.22533/at.ed.1595312602019
-
Palavras-chave: Cicatriz; acne vulgar; atrofia; insulina; terapêutica; equipamentos cirúrgicos.
-
Keywords: Cicatrix; acne vulgaris; atrophy; insulin; therapeutics; surgical equipment.
-
Abstract: INTRODUCTION: Atrophic acne scars result from changes in the extracellular matrix during the inflammatory process and have a significant functional and psychosocial impact. Human insulin has favorable effects on tissue regeneration; however, its application via microinfusion of drugs into the skin (MMP®) to treat atrophic acne scars remains underexplored. OBJECTIVES: To evaluate the clinical effects of the application of human insulin via MMP® to treat atrophic acne scars. METHODS: this pilot, analytical, uncontrolled study included eight participants who underwent three biweekly sessions of MMP® with regular human insulin. RESULTS: The mean age of the patients was 29.3 ± 6.9 years; with six women (75.0%). A clinical improvement was observed with favorable evaluations in termos of pain and patient satisfaction. CONCLUSION: Patients exhibited clinical improvement in the appearance of atrophic acne scars following MMP® treatment with human insulin. Moreover, they reported a high degree of satisfaction.
- AMANDA LUCAS FREIRE COSTA
- Patrícia de Barros Guimarães
- Maria de Fátima de Medeiros Brito
- Taís Regina Nascimento de Oliveira
- Pollyana de Souza Oliveira
- Karolayne Pereira Cavalcante